Related Experiment Video
Updated: Jun 13, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
2010 Multidisciplinary Head and Neck Cancer Symposium
Shao Hui Huang1, Brian O'Sullivan
1Princess Margaret Hospital/University of Toronto, 610 University Ave, Toronto, ON M5G 2M9, Canada.
Abstract:
The 2010 Multidisciplinary Head and Neck Cancer Symposium was held in Arizona on February 25-27, 2010 and sponsored by the American Head and Neck Society, American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, and Society of Nuclear Medicine. Expertise from various fields spanned topics that included diagnosis and management of skull-base malignancies; discovery and integration of biomarkers in clinical trials; organ preservation and functional outcomes; patient-centered care initiatives; functional imaging for head and neck cancer; and the treatment of recurrent disease. This meeting was informative and provocative in reporting the latest advances in the management of head and neck cancer. It provided the opportunity to gather expertise for interdisciplinary discussion and especially illustrated the challenges in managing these complex and heterogeneous diseases.
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
